A 1α,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice

Diabetes

Volumn 51, Issue 5, 2002, Pages 1367-1374

  Gregori, Silvia ^a   Giarratana, Nadia ^a   Smiroldo, Simona ^a   Uskokovic, Milan ^b   Adorini, Luciano ^a  

^a BioXell SpA   (Italy)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1ALPHA,25 DOHYDROXY 16,23 DIENE 26,27 HEXAFLUORO 19 NOR VITAMIN D3; AUTOANTIGEN; CALCITRIOL DERIVATIVE; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; RO 26 2198; UNCLASSIFIED DRUG; 1,25(OH)2 16 ENE 23 YNE 26,27 HEXAFLUORO 19 NOR D3; 1,25(OH)2-16-ENE-23-YNE-26,27-HEXAFLUORO-19-NOR-D3; COLECALCIFEROL; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOLOGY; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LYMPH NODE; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS ISLET;

ANIMALS; ANTIGENS, CD4; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE II; INTERLEUKIN-12; ISLETS OF LANGERHANS; LIPOPOLYSACCHARIDES; LYMPH NODES; MICE; MICE, INBRED NOD; MICE, SCID; RECEPTORS, INTERLEUKIN-2; TH1 CELLS;

EID: 0036020679     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.5.1367     Document Type: Article

References (50)

1. The NOD mouse model of type 1 diabetes: As good as it gets?
2. Cell death mediators in autoimmune diabetes-no shortage of suspects
3. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
4. Breaking self-tolerance in nonobese diabetic mice
5. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
6. Interleukin 12 and autoimmune diabetes
7. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T-cells that control autoimmune diabetes
8. Regulatory T-cells in autoimmmunity
9. Regulatory T cells in the control of immune pathology
10. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
11. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation
12. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25-subpopulations
13. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs
14. 1,25-Dihydroxyvitamin D 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis
15. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
16. 3
17. 3 attenuates the expression of experimental murine lupus of MRL/1 mice
18. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia
19. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis
20. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3
21. Recent developments in vitamin D analogs
22. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans
23. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population
24. Incidence of childhood-onset insulin-dependent diabetes mellitus: The EURODIAB ACE Study
25. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus
26. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions
27. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p 40 gene
28. Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice
29. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele
30. 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation
31. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes
32. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes
33. Measurement of human and mouse IL-12
34. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
35. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes
36. Immunomodulatory effects of 1,25-dihydroxyvitamin D3
37. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice
38. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A
39. Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways
40. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation
41. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA
42. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells
43. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro
44. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs
45. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo
46. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
47. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
48. 3 and mycophenolate mofetil treatment mediate transplantation tolerance
49. + suppressor T cells